Shelton Wealth Management LLC Purchases 273 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Shelton Wealth Management LLC lifted its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 6.7% in the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 4,359 shares of the exchange traded fund’s stock after acquiring an additional 273 shares during the period. Shelton Wealth Management LLC’s holdings in SPDR S&P Biotech ETF were worth $393,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in XBI. Healthcare of Ontario Pension Plan Trust Fund raised its holdings in SPDR S&P Biotech ETF by 198.6% in the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 9,229,000 shares of the exchange traded fund’s stock worth $911,825,000 after purchasing an additional 6,138,000 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd bought a new position in shares of SPDR S&P Biotech ETF in the 3rd quarter worth about $141,284,000. Northwestern Mutual Wealth Management Co. increased its stake in shares of SPDR S&P Biotech ETF by 1.6% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 1,145,049 shares of the exchange traded fund’s stock worth $106,158,000 after acquiring an additional 18,202 shares in the last quarter. Mirae Asset Securities USA Inc. lifted its position in SPDR S&P Biotech ETF by 50.0% during the 3rd quarter. Mirae Asset Securities USA Inc. now owns 900,000 shares of the exchange traded fund’s stock valued at $88,920,000 after acquiring an additional 300,000 shares during the period. Finally, Employees Retirement System of Texas boosted its stake in SPDR S&P Biotech ETF by 40.8% during the second quarter. Employees Retirement System of Texas now owns 603,857 shares of the exchange traded fund’s stock worth $55,984,000 after acquiring an additional 174,857 shares in the last quarter.

SPDR S&P Biotech ETF Stock Performance

Shares of NYSEARCA XBI opened at $87.97 on Friday. The company has a 50 day simple moving average of $94.09 and a two-hundred day simple moving average of $96.90. SPDR S&P Biotech ETF has a fifty-two week low of $81.14 and a fifty-two week high of $105.47. The company has a market capitalization of $6.71 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.